#2244

Giammaria Giuliani

Switzerland 48 years old

Overview

Source of Wealth
Pharmaceuticals
Industry
Healthcare
Residence
Montagnola
Marital Status
Married

Assets

  • HBM Healthcare Investments AG
    550,306 shares @ -
    -
    HBMN-CH
  • Royalty Pharma
    10,100,000 shares @ -
    -
    RPRX-US

Biography

Giammaria Giuliani is a healthcare investor who owns a 5% stake in Royalty Pharma, the world's largest acquirer of pharmaceutical royalties.

Royalty Pharma went public in 2020 and has collected revenue slices of blockbuster drugs like Humira, Imbruvica, Lyrica and Xtandi.

Giammaria and his brother Mario also own stakes in Swiss investment company HBM Healthcare Investments and a number of biotech firms in the U.S.

The brothers share ownership of their family's pharmaceutical company, Giuliani, founded by their great-grandfather Germano in Milan, Italy in 1889.

They also own real estate investments in Europe and the U.S., including a planned commercial and residential project on a maritime platform in Monaco.

About

The family company's best-known product is Amaro Giuliani, a herbal digestive remedy invented by Germano, a chemist, when he bought a pharmacy in Milan in 1889.